12. Volonte D, Galbiati F (2009) Inhibition of thioredoxin reductase 1 by caveolin 1 promotes stress-induced premature senescence. EMBO Rep 10: 1334–1340. 13. Volonte D, Kahkonen B, Shapiro S, Di Y, Galbiati F (2009) Caveolin-1 expression is required for the development of pulmonary emphysema through activation of the ATM-p53-p21 pathway. J Biol Chem 284: 5462–5466. 14. Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP (1997) Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 272: 6525–6533. 15. Jagannadham MV, Sharadadevi A, Nagaraj R (2002) Effects of deleting a tripeptide sequence observed in muscular dystrophy patients on the conforma- tion of synthetic peptides corresponding to the scaffolding domain of caveolin-3. Biochem Biophys Res Commun 298: 203–206. 16. Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer statistics, 2001. CA Cancer J Clin 51: 15–36. 17. Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, et al. (2000) The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer. Cancer 88: 2398–2424. 18. Fine SW, Lisanti MP, Galbiati F, Li M (2001) Elevated expression of caveolin-1 in adenocarcinoma of the colon. Am J Clin Pathol 115: 719–724. 19. Kim HA, Kim KH, Lee RA (2006) Expression of caveolin-1 is correlated with Akt-1 in colorectal cancer tissues. Exp Mol Pathol 80: 165–170. 20. Patlolla JM, Swamy MV, Raju J, Rao CV (2004) Overexpression of caveolin-1 in experimental colon adenocarcinomas and human colon cancer cell lines. Oncol Rep 11: 957–963. 21. Featherstone C, Jackson SP (1999) Ku, a DNA repair protein with multiple cellular functions? Mutat Res 434: 3–15. 22. Kim SH, Kim D, Han JS, Jeong CS, Chung BS, et al. (1999) Ku autoantigen affects the susceptibility to anticancer drugs. Cancer Res 59: 4012–4017. 23. Ouyang H, Nussenzweig A, Kurimasa A, Soares VC, Li X, et al. (1997) Ku70 is required for DNA repair but not for T cell antigen receptor gene recombination In vivo. J Exp Med 186: 921–929. 24. Chechlacz M, Vemuri MC, Naegele JR (2001) Role of DNA-dependent protein kinase in neuronal survival. J Neurochem 78: 141–154. 25. Cohen HY, Lavu S, Bitterman KJ, Hekking B, Imahiyerobo TA, et al. (2004) Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax- mediated apoptosis. Mol Cell 13: 627–638. Caveolin-1, a Novel Ku70-Interacting Protein 26. Gomez JA, Gama V, Yoshida T, Sun W, Hayes P, et al. (2007) Bax-inhibiting peptides derived from Ku70 and cell-penetrating pentapeptides. Biochem Soc Trans 35: 797–801. 27. Yoshida T, Tomioka I, Nagahara T, Holyst T, Sawada M, et al. (2004) Bax- inhibiting peptide derived from mouse and rat Ku70. Biochem Biophys Res Commun 321: 961–966. 28. Hwang PM, Bunz F, Yu J, Rago C, Chan TA, et al. (2001) Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat Med 7: 1111–1117. 29. Nechushtan A, Smith CL, Hsu YT, Youle RJ (1999) Conformation of the Bax C-terminus regulates subcellular location and cell death. Embo J 18: 2330–2341. 30. Suzuki M, Youle RJ, Tjandra N (2000) Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 103: 645–654. 31. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B (2000) Role of BAX in the apoptotic response to anticancer agents. Science 290: 989–992. 32. Hasenjager A, Gillissen B, Muller A, Normand G, Hemmati PG, et al. (2004) Smac induces cytochrome c release and apoptosis independently from Bax/Bcl- x(L) in a strictly caspase-3-dependent manner in human carcinoma cells. Oncogene 23: 4523–4535. 33. Tessner TG, Muhale F, Riehl TE, Anant S, Stenson WF (2004) Prostaglandin E2 reduces radiation-induced epithelial apoptosis through a mechanism involving AKT activation and bax translocation. J Clin Invest 114: 1676–1685. 34. Brito RA, Medgyesy D, Zukowski TH, Royce ME, Ravandi-Kashani F, et al. (1999) Fluoropyrimidines: a critical evaluation. Oncology 57 Suppl 1: 2–8. 35. Selga E, Morales C, Noe V, Peinado MA, Ciudad CJ (2008) Role of caveolin 1, E-cadherin, Enolase 2 and PKCalpha on resistance to methotrexate in human HT29 colon cancer cells. BMC Med Genomics 1: 35. 36. Tencer L, Burgermeister E, Ebert MP, Liscovitch M (2008) Rosiglitazone induces caveolin-1 by PPARgamma-dependent and PPRE-independent mech- anisms: the role of EGF receptor signaling and its effect on cancer cell drug resistance. Anticancer Res 28: 895–906. 37. Goetz JG, Lajoie P, Wiseman SM, Nabi IR (2008) Caveolin-1 in tumor progression: the good, the bad and the ugly. Cancer Metastasis Rev 27: 715– 735. 38. Zhu H, Yue J, Pan Z, Wu H, Cheng Y, et al. (2010) Involvement of Caveolin-1 in repair of DNA damage through both homologous recombination and non- homologous end joining. PLoS One 5: e12055. PLoS ONE | www.plosone.org 12 June 2012 | Volume 7 | Issue 6 | e39379